Home » Healthcare » Pharmaceuticals » Pharma Grade Glycine Market

Pharma Grade Glycine Market By Grade (USP Grade, EP Grade, JP Grade); By Application (Pharmaceuticals, Nutraceuticals, Personal Care, Others); By Distribution Channel (Pharmaceuticals/Nutraceuticals, Food Additives, Feed Additives, Personal Care Products) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Summary
Table Of Content

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
Pharma Grade Glycine Market Size 2024	USD 1,722.42 million
Pharma Grade Glycine Market, CAGR	7.45%
Pharma Grade Glycine Market Size 2032	USD 3,187.14 million

Market Overview:

The Global Pharma Grade Glycine Market size was valued at USD 1,090.84 million in 2018 to USD 1,722.42 million in 2024 and is anticipated to reach USD 3,187.14 million by 2032, at a CAGR of 7.45% during the forecast period.

Several factors are propelling the growth of the pharma-grade glycine market. The rising prevalence of chronic diseases such as cardiovascular disorders, diabetes, and neurological conditions has heightened the need for effective pharmaceutical interventions. Glycine’s role as a buffering agent and stabilizer in injectable medications enhances drug efficacy and shelf-life, making it indispensable in modern medicine. Additionally, the surge in demand for personalized medicine and biologic therapies necessitates the use of high-quality excipients like pharma-grade glycine to ensure the stability and bioavailability of active pharmaceutical ingredients (APIs). Moreover, advancements in healthcare infrastructure and increased healthcare expenditures globally are contributing to the market’s expansion.

Regionally, the pharma-grade glycine market exhibits varied dynamics. North America holds a significant share, driven by a robust pharmaceutical industry and substantial healthcare investments. The United States, in particular, is witnessing steady growth in the demand for pharma-grade glycine, fueled by its application in precision medicine and niche pharmaceutical segments. Europe also maintains a strong position, with countries like Germany and the United Kingdom emphasizing the use of natural ingredients in pharmaceuticals, thereby boosting the demand for high-purity glycine. In the Asia-Pacific region, emerging markets such as China and India are experiencing rapid industrialization and healthcare improvements, leading to an increased requirement for pharma-grade glycine in drug manufacturing. These regions are expected to witness the fastest growth during the forecast period, owing to favorable government policies and expanding pharmaceutical manufacturing capabilities.

Market Insights:

The global pharma grade glycine market was valued at USD 1,090.84 million in 2018 and is expected to reach USD 3,187.14 million by 2032, growing at a CAGR of 7.45% during the forecast period.
The increasing demand for pharmaceutical excipients is a key driver of the market, with pharma-grade glycine playing a vital role in stabilizing drugs and ensuring their efficacy, particularly in biologics and injectable formulations.
The rising prevalence of chronic diseases like cardiovascular disorders, diabetes, and neurological conditions is propelling the demand for stable and effective drug treatments, further boosting the market for pharma-grade glycine.
Personalized medicine and precision therapies are transforming the healthcare industry, creating a strong demand for high-quality excipients like pharma-grade glycine to support the stability and efficacy of tailored drug formulations.
Emerging economies in Asia-Pacific, especially China and India, are expanding their pharmaceutical manufacturing capabilities, leading to increased demand for pharma-grade glycine in drug production.
Regulatory compliance and maintaining quality standards are challenges faced by pharma-grade glycine manufacturers, with adherence to global standards like GMP and FDA regulations necessary for product development and market entry.
Sourcing high-quality raw materials for the production of pharma-grade glycine can be challenging due to price volatility and supply chain disruptions, which may impact production timelines and overall costs.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research!

Download Sample

Market Drivers:

Increasing Demand for Pharmaceutical Excipients

The growing use of high-quality pharmaceutical excipients is one of the primary drivers of the global pharma grade glycine market. Pharmaceutical-grade glycine plays a crucial role in enhancing the stability, solubility, and bioavailability of drugs, particularly injectable formulations. With an increasing number of injectable drugs and biologic therapies being developed, the demand for glycine in these formulations is expanding. It helps maintain the integrity and effectiveness of active pharmaceutical ingredients (APIs), ensuring their therapeutic efficacy over time. The increasing trend toward biopharmaceuticals and biologics is further boosting the demand for specialized excipients like glycine.

Surge in Chronic Diseases and Therapeutic Requirements

The rising prevalence of chronic diseases, such as cardiovascular diseases, diabetes, and neurological disorders, is driving the demand for pharmaceutical products that require excipients like pharma-grade glycine. As these diseases continue to affect a large segment of the global population, there is a heightened need for effective drug treatments that rely on stable and high-quality components. Pharmaceutical-grade glycine plays an essential role in drug formulations by acting as a stabilizer and buffering agent. Its inclusion in therapeutic drugs ensures proper dosing, effectiveness, and patient safety, which is crucial for treating chronic conditions efficiently.

For instance, Evonik Industries has increased its production capacity for pharmaceutical-grade glycine by 50 percent at its Nanning, China site, driven by efficiency gains in the production process and strong demand for glycine in chronic disease therapies.

Growth in Personalized Medicine and Precision Therapy

Personalized medicine is transforming the healthcare landscape, and it significantly impacts the pharmaceutical excipient market, including pharma-grade glycine. As treatments become more tailored to individual genetic profiles, the need for precision in drug formulations increases. Glycine’s role in stabilizing biologic drugs, ensuring their safe delivery, and maintaining efficacy during storage aligns with the growing trend of personalized therapies. The rise of precision medicine, which demands high-quality excipients for customized drug delivery, is positioning glycine as a critical ingredient in the pharmaceutical industry.

For instance, Ajinomoto’s StemFit™ media are specifically designed for stem cell research and clinical cell therapy production, complying with strict regulatory standards and enabling consistent, safe results in the development of cell therapy products.

Expansion of Pharmaceutical Manufacturing in Emerging Economies

The pharmaceutical manufacturing capabilities in emerging economies, particularly in regions such as Asia-Pacific, are rapidly expanding, creating new growth opportunities for the global pharma grade glycine market. As countries like China and India continue to develop their pharmaceutical production capacities, the demand for excipients to support these expanded manufacturing operations is also on the rise. These countries are increasingly adopting advanced technologies and modern drug formulation practices that incorporate pharma-grade glycine to enhance drug performance and ensure compliance with international quality standards. The growth of these markets will be a key factor in the continued expansion of the pharma-grade glycine market.

Market Trends:

Increasing Focus on Biopharmaceuticals and Injectable Formulations

The increasing focus on biopharmaceuticals and injectable formulations is one of the key trends shaping the global pharma grade glycine market. With the rise of biologic drugs, which are often injectable, there is a growing need for excipients that ensure the stability and efficacy of these complex therapies. Pharma-grade glycine serves a critical role in maintaining the integrity of biologic drugs during manufacturing and storage. It helps stabilize protein-based drugs and prevent denaturation, ensuring that the therapeutic effects are delivered effectively to patients. This trend is expected to continue as the demand for biologic drugs and injectable treatments increases across various therapeutic areas.

For instance, Pfanstiehl produces a high-purity, low-endotoxin glycine specifically designed for injectable biologic and vaccine formulations, manufactured under ICH-Q7 cGMP conditions in the United States to ensure batch-to-batch consistency and compliance with global pharmacopoeia standards.

Growing Adoption of Personalized Medicine

Personalized medicine is a significant trend that is influencing the pharma-grade glycine market. As medicine becomes more tailored to individual genetic profiles and specific conditions, the demand for high-quality excipients to support precision therapy increases. Pharma-grade glycine is essential in maintaining the stability and functionality of biologics and gene therapies used in personalized medicine. It helps preserve the active ingredients of these specialized treatments, ensuring that they remain effective throughout the course of treatment. This trend toward precision therapies is expected to drive further growth in the market for pharma-grade glycine as more treatments require customized excipients.

Shift Towards Sustainable and Green Manufacturing Practices

Sustainability is an emerging trend within the pharmaceutical industry, and it is influencing the global pharma grade glycine market. Pharmaceutical manufacturers are increasingly focusing on sustainable practices, including the use of renewable and biodegradable excipients. This trend is driven by environmental concerns, regulatory pressures, and the growing demand for eco-friendly products. Pharma-grade glycine is being produced using more sustainable methods, such as plant-based sources, to reduce the environmental footprint of its manufacturing. The growing emphasis on sustainability in the pharmaceutical industry is expected to create opportunities for growth in the pharma-grade glycine market, particularly among environmentally conscious manufacturers.

Advancements in Drug Delivery Systems

Advancements in drug delivery systems are shaping the demand for pharma-grade glycine. New drug delivery methods, such as controlled-release formulations, targeted therapies, and nanotechnology, require precise and stable excipients to ensure the effective release of drugs. Pharma-grade glycine plays a crucial role in these advanced drug delivery systems, where it is used to stabilize formulations and enhance their bioavailability. As drug delivery technologies evolve to offer more targeted and efficient therapies, the role of excipients like glycine will become even more vital. The adoption of these advanced drug delivery systems is expected to drive the demand for high-quality pharma-grade glycine in the coming years.

For instance, a study demonstrated that microspheres composed of bovine serum albumin (BSA) and glycine provided sustained release of resveratrol, protecting the drug from high temperature and oxygen stress, and achieving ideal physicochemical characteristics for oral delivery.

Market Challenges Analysis:

Regulatory and Quality Compliance Challenges

One of the significant challenges facing the global pharma grade glycine market is navigating the stringent regulatory requirements and ensuring compliance with global quality standards. The pharmaceutical industry is highly regulated, with strict guidelines governing the production and use of excipients like pharma-grade glycine. Manufacturers must adhere to Good Manufacturing Practices (GMP) and other regulatory standards set by agencies such as the FDA and EMA. This complexity in regulatory approval processes can slow down product development and increase operational costs. Maintaining consistent product quality while meeting these regulations demands significant investments in quality control systems and compliance monitoring, posing a challenge for market players seeking to scale operations.

Raw Material Sourcing and Price Volatility

Sourcing high-quality raw materials for pharma-grade glycine production can be a challenge due to price volatility and supply chain disruptions. Glycine is primarily derived from natural sources, and fluctuations in the availability of these raw materials can affect production timelines and costs. The rising cost of raw materials, coupled with supply chain issues caused by global economic factors or geopolitical tensions, can impact the overall profitability of pharma-grade glycine manufacturers. Furthermore, the increasing demand for sustainable production practices adds an extra layer of complexity, as sourcing plant-based raw materials requires efficient logistics and traceability. These factors contribute to cost pressures and pose a challenge to manufacturers aiming to maintain price stability while ensuring high-quality production.

Market Opportunities:

Expansion of Biopharmaceutical and Gene Therapy Markets

The growing focus on biopharmaceuticals and gene therapies presents significant opportunities for the global pharma grade glycine market. As the demand for biologics and personalized medicine rises, the need for high-quality excipients like pharma-grade glycine will increase. It plays a crucial role in stabilizing protein-based drugs and gene therapies, ensuring their effectiveness and safety. The development of advanced biologic treatments, such as monoclonal antibodies and CAR-T cell therapies, offers substantial growth potential for the market. As these therapies become more prevalent, pharma-grade glycine will continue to be a vital component in maintaining drug stability and bioavailability.

Growing Demand for Sustainable and Green Excipients

Sustainability trends within the pharmaceutical industry also create significant opportunities for the pharma grade glycine market. Increasing pressure from regulatory bodies and consumers to adopt eco-friendly practices is driving manufacturers to seek sustainable alternatives in their production processes. The demand for plant-based and biodegradable excipients is growing, and pharma-grade glycine, produced from renewable sources, aligns with these environmental goals. As pharmaceutical companies aim to reduce their environmental footprint, they are likely to invest more in sustainable glycine production methods, opening new avenues for growth in the market. This shift toward greener solutions presents an opportunity for manufacturers to capture new market segments focused on sustainability.

Market Segmentation Analysis:

By grade segment, USP grade holds a significant share due to its widespread use in pharmaceutical applications. EP and JP grades also play an essential role, particularly in European and Japanese pharmaceutical formulations, which require stringent compliance with regional quality standards. These grades ensure the stability and effectiveness of glycine in various drug formulations, particularly injectables.

For instance, Pfanstiehl offers USP, EP, and JP grade glycine, each manufactured to meet the specific monograph requirements of the United States Pharmacopeia (USP), European Pharmacopoeia (EP), and Japanese Pharmacopoeia (JP). Their USP grade glycine is widely used in injectable pharmaceutical formulations in the U.S., while EP and JP grades are supplied to European and Japanese pharmaceutical companies to ensure compliance with stringent regional standards.

By application segment, pharmaceuticals dominate the market, driven by the increasing use of pharma-grade glycine in injectable drugs, biologics, and personalized medicine. The nutraceuticals sector is also growing as demand for dietary supplements and functional foods increases. Personal care products utilize pharma-grade glycine for its stabilizing properties, while the “Others” category includes applications in research and chemical manufacturing.

By distribution channel segment shows that pharmaceuticals and nutraceuticals account for a significant share, as these sectors require high-purity excipients for drug formulations and dietary products. The growing use of food additives and feed additives has expanded the application of pharma-grade glycine beyond traditional pharmaceuticals. Personal care products are also experiencing an increase in demand for glycine, which is utilized for its hydrating and stabilizing effects in cosmetic formulations.

For instance, Evonik Industries AG offers pharma-grade glycine through its Health Care division, manufactured under ICH Q7-compliant Good Manufacturing Practices (GMP). The company supplies glycine that meets global pharmacopeia standards, including USP, EP, and JP, ensuring suitability for use in parenteral nutrition, oral formulations, and active pharmaceutical ingredient (API) development.

Segmentation:

By Grade

USP Grade
EP Grade
JP Grade

By Application

Pharmaceuticals
Nutraceuticals
Personal Care
Others

By Distribution Channel

Pharmaceuticals/Nutraceuticals
Food Additives
Feed Additives
Personal Care Products

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Regional Analysis:

North America Pharma Grade Glycine Market

The North America pharma grade glycine market size was valued at USD 347.50 million in 2018 to USD 540.88 million in 2024 and is anticipated to reach USD 1,004.67 million by 2032, growing at a CAGR of 7.50% during the forecast period. North America holds a significant market share in the global pharma grade glycine market, driven primarily by the robust pharmaceutical industry in the United States. The demand for pharma-grade glycine is bolstered by the increasing use of biologic and injectable drugs, which require high-quality excipients for stability and bioavailability. Regulatory support for pharmaceutical advancements, along with substantial healthcare spending, also contribute to the market’s growth. The increasing focus on biopharmaceuticals and personalized medicine further strengthens the demand for pharma-grade glycine in this region.

Europe Pharma Grade Glycine Market

The Europe pharma grade glycine market size was valued at USD 246.90 million in 2018 to USD 372.24 million in 2024 and is anticipated to reach USD 637.79 million by 2032, growing at a CAGR of 6.40% during the forecast period. Europe has a well-established pharmaceutical sector, particularly in countries like Germany, France, and the United Kingdom, which is driving the growth of pharma-grade glycine. The rising demand for biologics and personalized therapies, along with an increasing emphasis on high-quality excipients, contributes to the region’s market expansion. Europe’s strict regulatory environment and focus on sustainable pharmaceutical practices are also influencing the demand for eco-friendly and high-quality pharma-grade glycine.

Asia Pacific Pharma Grade Glycine Market

The Asia Pacific pharma grade glycine market size was valued at USD 413.93 million in 2018 to USD 681.37 million in 2024 and is anticipated to reach USD 1,348.90 million by 2032, growing at a CAGR of 8.40% during the forecast period. This region is expected to witness the highest growth rate due to rapid industrialization and the expansion of the pharmaceutical manufacturing sector in countries like China and India. The rising adoption of advanced drug delivery systems and an increase in healthcare investments are driving the demand for pharma-grade glycine. Asia Pacific’s cost-effective production capabilities and growing pharmaceutical exports further contribute to its market share in the global pharma-grade glycine market.

Latin America Pharma Grade Glycine Market

The Latin America pharma grade glycine market size was valued at USD 39.64 million in 2018 to USD 61.58 million in 2024 and is anticipated to reach USD 96.87 million by 2032, growing at a CAGR of 5.30% during the forecast period. The pharmaceutical industry in Latin America is evolving, with increasing investments in healthcare infrastructure and the rising demand for high-quality pharmaceuticals. As the demand for biologics and specialty drugs rises, pharma-grade glycine is becoming an essential ingredient for drug formulation in the region. The growing focus on regulatory compliance and improvements in manufacturing capabilities will further support the growth of the pharma-grade glycine market in Latin America.

Middle East Pharma Grade Glycine Market

The Middle East pharma grade glycine market size was valued at USD 28.85 million in 2018 to USD 41.41 million in 2024 and is anticipated to reach USD 63.88 million by 2032, growing at a CAGR of 5.00% during the forecast period. The Middle East is experiencing rapid advancements in its pharmaceutical sector, driven by government initiatives to improve healthcare services and manufacturing capabilities. The demand for pharma-grade glycine in the region is increasing due to the rising need for high-quality excipients in biologic and specialty drug formulations. The pharmaceutical market’s growth, especially in countries like Saudi Arabia and the UAE, presents significant opportunities for the global pharma grade glycine market.

Africa Pharma Grade Glycine Market

The Africa pharma grade glycine market size was valued at USD 14.02 million in 2018 to USD 24.93 million in 2024 and is anticipated to reach USD 35.04 million by 2032, growing at a CAGR of 3.80% during the forecast period. The pharmaceutical industry in Africa is growing, supported by increasing investments in healthcare infrastructure and improvements in manufacturing capabilities. However, the market remains in the early stages of development, with demand primarily driven by the expansion of local drug production facilities and increasing access to quality medicines. The need for high-quality excipients such as pharma-grade glycine in the production of injectable and biologic drugs will likely contribute to the region’s market growth over the forecast period.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis:

Showa Denko KK
Chattem Chemicals
Paras Intermediates Private Limited
Evonik
Shijiazhuang Donghua Jinlong Chemical
GEO Specialty Chemicals
Linxi Hongtai
Hubei Xingfa Chemicals Group
Zhenxing Chemical
Newtrend Group

Competitive Analysis:

The global pharma grade glycine market is highly competitive, with several key players focused on expanding their product portfolios and market presence. Leading companies in the market include major chemical and pharmaceutical manufacturers who specialize in the production of high-quality excipients for drug formulations. These companies are continuously innovating to improve the purity and sustainability of their products to meet the growing demand for biologics, gene therapies, and personalized medicines. Intense competition drives investments in research and development to develop more effective and stable formulations, ensuring that pharma-grade glycine remains an essential component in drug production. Regional players are also increasingly emerging, especially in Asia Pacific, where manufacturing costs are lower, and production capacity is expanding. Companies differentiate themselves through product quality, supply chain efficiency, and compliance with global regulatory standards. This competitive landscape encourages continuous growth and innovation within the global pharma grade glycine market.

Market Concentration & Characteristics:

The global pharma grade glycine market is moderately concentrated, with a few large players holding a significant share, while several regional companies contribute to market growth. Leading players focus on product innovation, quality control, and regulatory compliance to maintain competitive advantages. Market characteristics include a strong emphasis on high purity standards to meet the demands of the pharmaceutical industry, especially in biologics and injectable formulations. The market also sees increasing investments in sustainable production processes, aligning with the growing demand for eco-friendly manufacturing practices. Due to the rising demand for high-quality excipients, competition in the market is intensifying, with companies striving to enhance their production capabilities and expand their geographical presence. This competitive landscape ensures continuous growth in the global pharma grade glycine market, driven by innovation, quality assurance, and regulatory adherence.

Report Coverage:

The research report offers an in-depth analysis based on grade, application, and distribution channel, It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook:

The global pharma grade glycine market is expected to witness steady growth driven by increasing demand for biologics and injectable drugs.
Expansion of personalized medicine and gene therapies will significantly boost the demand for high-quality excipients like pharma-grade glycine.
Rising healthcare investments in emerging markets, particularly in Asia Pacific, will contribute to increased consumption of pharma-grade glycine.
The shift towards sustainable production practices will drive innovation in eco-friendly sourcing and manufacturing methods for pharma-grade glycine.
The growing prevalence of chronic diseases will increase the need for stable and effective drug formulations, enhancing the market’s demand.
Advances in drug delivery systems, including targeted therapies, will create new opportunities for pharma-grade glycine applications.
Regulatory standards will continue to tighten, pushing manufacturers to focus on product quality and compliance.
The competitive landscape will intensify, with both global and regional players expanding their market share through strategic partnerships.
Technological advancements in production processes will enable cost-effective manufacturing, benefiting the market’s growth.
Market fragmentation is expected to persist, with a mix of established leaders and new entrants catering to regional and niche demands.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : PHARMA GRADE GLYCINE MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview

3.2 Catalysts of Expansion – Key Market Drivers

3.2.1 Momentum Boosters – Growth Triggers

3.2.2 Innovation Fuel – Disruptive Technologies

3.3 Headwinds & Crosswinds – Market Restraints

3.3.1 Regulatory Tides – Compliance Challenges

3.3.2 Economic Frictions – Inflationary Pressures

3.4 Untapped Horizons – Growth Potential & Opportunities

3.5 Strategic Navigation – Industry Frameworks

3.5.1 Market Equilibrium – Porter’s Five Forces

3.5.2 Ecosystem Dynamics – Value Chain Analysis

3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend

3.6.2 Price Trend by product

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Application Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Grade & Application Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1.Import Analysis by Region

6.1.1. Global Pharma Grade Glycine Market Import Volume By Region

6.2.Export Analysis by Region

6.2.1. Global Pharma Grade Glycine Market Export Volume By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1.Company Market Share Analysis

7.1.1. Global Pharma Grade Glycine Market: Company Market Share

7.1. Global Pharma Grade Glycine Market Company Volume Market Share

7.2. Global Pharma Grade Glycine Market Company Revenue Market Share

7.3.Strategic Developments

7.3.1.Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : PHARMA GRADE GLYCINE MARKET – BY GRADE SEGMENT ANALYSIS

8.1.Pharma Grade Glycine Market Overview by Grade Segment

8.1.1. Pharma Grade Glycine Market Volume Share By Grade

8.1.2. Pharma Grade Glycine Market Revenue Share By Grade

8.2. USP Grade

8.3. EP Grade

8.4. JP Grade

CHAPTER NO. 9 : PHARMA GRADE GLYCINE MARKET – BY APPLICATION SEGMENT ANALYSIS

9.1.Pharma Grade Glycine Market Overview by Application Segment

9.1.1. Pharma Grade Glycine Market Volume Share By Application

9.1.2. Pharma Grade Glycine Market Revenue Share By Application

9.2. Pharmaceuticals

9.3. Nutraceuticals

9.4. Personal Care

9.5. Others

CHAPTER NO. 10 : PHARMA GRADE GLYCINE MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS

10.1.Pharma Grade Glycine Market Overview by Distribution Channel Segment

10.1.1. Pharma Grade Glycine Market Volume Share By Distribution Channel

10.1.2. Pharma Grade Glycine Market Revenue Share By Distribution Channel

10.2. Pharmaceuticals/Nutraceuticals

10.3. Food Additives

10.4. Feed Additives

10.5. Personal Care Products

CHAPTER NO. 11 : PHARMA GRADE GLYCINE MARKET – REGIONAL ANALYSIS

11.1.Pharma Grade Glycine Market Overview by Region Segment

11.1.1. Global Pharma Grade Glycine Market Volume Share By Region

11.1.2. Global Pharma Grade Glycine Market Revenue Share By Region

11.1.3.Regions

11.1.4.Global Pharma Grade Glycine Market Volume By Region

11.1.5.Global Pharma Grade Glycine Market Revenue By Region

11.1.6.Grade

11.1.7.Global Pharma Grade Glycine Market Volume By Grade

11.1.8.Global Pharma Grade Glycine Market Revenue By Grade

11.1.9.Application

11.1.10. Global Pharma Grade Glycine Market Volume By Application

11.1.11. Global Pharma Grade Glycine Market Revenue By Application

11.1.12. Distribution Channel

11.1.13. Global Pharma Grade Glycine Market Volume By Distribution Channel

11.1.14. Global Pharma Grade Glycine Market Revenue By Distribution Channel

CHAPTER NO. 12 : NORTH AMERICA PHARMA GRADE GLYCINE MARKET – COUNTRY ANALYSIS

12.1. North America Pharma Grade Glycine Market Overview by Country Segment

12.1.1.North America Pharma Grade Glycine Market Volume Share By Region

12.1.2. North America Pharma Grade Glycine Market Revenue Share By Region

12.2.North America

12.2.1.North America Pharma Grade Glycine Market Volume By Country

12.2.2.North America Pharma Grade Glycine Market Revenue By Country

12.2.3.Grade

12.2.4.North America Pharma Grade Glycine Market Volume By Grade

12.2.5.North America Pharma Grade Glycine Market Revenue By Grade

12.2.6.Application

12.2.7.North America Pharma Grade Glycine Market Volume By Application

12.2.8. North America Pharma Grade Glycine Market Revenue By Application

12.2.9.Distribution Channel

12.2.10. North America Pharma Grade Glycine Market Volume By Distribution Channel

12.2.11. North America Pharma Grade Glycine Market Revenue By Distribution Channel

12.3.U.S.

12.4.Canada

12.5.Mexico

CHAPTER NO. 13 : EUROPE PHARMA GRADE GLYCINE MARKET – COUNTRY ANALYSIS

13.1. Europe Pharma Grade Glycine Market Overview by Country Segment

13.1.1. Europe Pharma Grade Glycine Market Volume Share By Region

13.1.2. Europe Pharma Grade Glycine Market Revenue Share By Region

13.2.Europe

13.2.1.Europe Pharma Grade Glycine Market Volume By Country

13.2.2.Europe Pharma Grade Glycine Market Revenue By Country

13.2.3.Grade

13.2.4.Europe Pharma Grade Glycine Market Volume By Grade

13.2.5.Europe Pharma Grade Glycine Market Revenue By Grade

13.2.6.Application

13.2.7. Europe Pharma Grade Glycine Market Volume By Application

13.2.8. Europe Pharma Grade Glycine Market Revenue By Application

13.2.9.Distribution Channel

13.2.10. Europe Pharma Grade Glycine Market Volume By Distribution Channel

13.2.11. Europe Pharma Grade Glycine Market Revenue By Distribution Channel

13.3.UK

13.4.France

13.5.Germany

13.6.Italy

13.7.Spain

13.8.Russia

13.9. Rest of Europe

CHAPTER NO. 14 : ASIA PACIFIC PHARMA GRADE GLYCINE MARKET – COUNTRY ANALYSIS

14.1.Asia Pacific Pharma Grade Glycine Market Overview by Country Segment

14.1.1.Asia Pacific Pharma Grade Glycine Market Volume Share By Region

14.1.2.Asia Pacific Pharma Grade Glycine Market Revenue Share By Region

14.2.Asia Pacific

14.2.1. Asia Pacific Pharma Grade Glycine Market Volume By Country

14.2.2.Asia Pacific Pharma Grade Glycine Market Revenue By Country

14.2.3.Grade

14.2.4.Asia Pacific Pharma Grade Glycine Market Volume By Grade

14.2.5.Asia Pacific Pharma Grade Glycine Market Revenue By Grade

14.2.6.Application

14.2.7.Asia Pacific Pharma Grade Glycine Market Volume By Application

14.2.8.Asia Pacific Pharma Grade Glycine Market Revenue By Application

14.2.9.Distribution Channel

14.2.10. Asia Pacific Pharma Grade Glycine Market Volume By Distribution Channel

14.2.11. Asia Pacific Pharma Grade Glycine Market Revenue By Distribution Channel

14.3.China

14.4.Japan

14.5.South Korea

14.6.India

14.7.Australia

14.8.Southeast Asia

14.9. Rest of Asia Pacific

CHAPTER NO. 15 : LATIN AMERICA PHARMA GRADE GLYCINE MARKET – COUNTRY ANALYSIS

15.1. Latin America Pharma Grade Glycine Market Overview by Country Segment

15.1.1.Latin America Pharma Grade Glycine Market Volume Share By Region

15.1.2.Latin America Pharma Grade Glycine Market Revenue Share By Region

15.2. Latin America

15.2.1. Latin America Pharma Grade Glycine Market Volume By Country

15.2.2.Latin America Pharma Grade Glycine Market Revenue By Country

15.2.3.Grade

15.2.4. Latin America Pharma Grade Glycine Market Volume By Grade

15.2.5. Latin America Pharma Grade Glycine Market Revenue By Grade

15.2.6.Application

15.2.7.Latin America Pharma Grade Glycine Market Volume By Application

15.2.8.Latin America Pharma Grade Glycine Market Revenue By Application

15.2.9.Distribution Channel

15.2.10. Latin America Pharma Grade Glycine Market Volume By Distribution Channel

15.2.11. Latin America Pharma Grade Glycine Market Revenue By Distribution Channel

15.3.Brazil

15.4.Argentina

15.5.Rest of Latin America

CHAPTER NO. 16 : MIDDLE EAST PHARMA GRADE GLYCINE MARKET – COUNTRY ANALYSIS

16.1.Middle East Pharma Grade Glycine Market Overview by Country Segment

16.1.1.Middle East Pharma Grade Glycine Market Volume Share By Region

16.1.2. Middle East Pharma Grade Glycine Market Revenue Share By Region

16.2.Middle East

16.2.1. Middle East Pharma Grade Glycine Market Volume By Country

16.2.2.Middle East Pharma Grade Glycine Market Revenue By Country

16.2.3.Grade

16.2.4.Middle East Pharma Grade Glycine Market Volume By Grade

16.2.5.Middle East Pharma Grade Glycine Market Revenue By Grade

16.2.6.Application

16.2.7.Middle East Pharma Grade Glycine Market Volume By Application

16.2.8.Middle East Pharma Grade Glycine Market Revenue By Application

16.2.9. Distribution Channel

16.2.10. Middle East Pharma Grade Glycine Market Volume By Distribution Channel

16.2.11. Middle East Pharma Grade Glycine Market Revenue By Distribution Channel

16.3.GCC Countries

16.4. Israel

16.5. Turkey

16.6.Rest of Middle East

CHAPTER NO. 17 : AFRICA PHARMA GRADE GLYCINE MARKET – COUNTRY ANALYSIS

17.1. Africa Pharma Grade Glycine Market Overview by Country Segment

17.1.1.Africa Pharma Grade Glycine Market Volume Share By Region

17.1.2. Africa Pharma Grade Glycine Market Revenue Share By Region

17.2. Africa

17.2.1.Africa Pharma Grade Glycine Market Volume By Country

17.2.2.Africa Pharma Grade Glycine Market Revenue By Country

17.2.3.Grade

17.2.4.Africa Pharma Grade Glycine Market Volume By Grade

17.2.5.Africa Pharma Grade Glycine Market Revenue By Grade

17.2.6.Application

17.2.7. Africa Pharma Grade Glycine Market Volume By Application

17.2.8. Africa Pharma Grade Glycine Market Revenue By Application

17.2.9.Distribution Channel

17.2.10. Africa Pharma Grade Glycine Market Volume By Distribution Channel

17.2.11. Africa Pharma Grade Glycine Market Revenue By Distribution Channel

17.3. South Africa

17.4.Egypt

17.5.Rest of Africa

CHAPTER NO. 18 : COMPANY PROFILES

18.1. Showa Denko KK

18.1.1.Company Overview

18.1.2.Product Portfolio

18.1.3.Financial Overview

18.1.4.Recent Developments

18.1.5.Growth Strategy

18.1.6.SWOT Analysis

18.2. Chattem Chemicals

18.3. Paras Intermediates Private Limited

18.4. Evonik

18.5. Shijiazhuang Donghua Jinlong Chemical

18.6. GEO Specialty Chemicals

18.7. Linxi Hongtai

18.8. Hubei Xingfa Chemicals Group

18.9. Zhenxing Chemical

18.10. Newtrend Group

Frequently Asked Questions

What is the current size of the Global Pharma Grade Glycine Market?

The global pharma grade glycine market was valued at USD 1,090.84 million in 2018 and is projected to reach USD 3,187.14 million by 2032, growing at a CAGR of 7.45% during the forecast period.

What factors are driving the growth of the Global Pharma Grade Glycine Market?

Key factors include the rising prevalence of chronic diseases, the increasing demand for biologics and personalized medicine, and the essential role of pharma-grade glycine in stabilizing injectable medications and enhancing drug efficacy.

What are some challenges faced by the Global Pharma Grade Glycine Market?

Challenges include regulatory compliance, maintaining product quality, and managing the fluctuating cost and availability of raw materials required for the production of pharma-grade glycine.

Who are the major players in the Global Pharma Grade Glycine Market?

Major players include large chemical and pharmaceutical companies that specialize in the production of excipients, as well as regional players catering to specific geographic markets with specialized offerings.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Reviewed By
Gunakesh Parmar

Research Consultant

With over 15 years of dedicated experience in market research since 2009, specializes in delivering actionable insights from data.

View Profile

Purchase Options

Single User

$4699

Multi User

$5699

Custom Report

$12699

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

EMAIL US

Request Sample

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –